Autologous Intra-Articular Micro-Fragmented Adipose Transfer for the Treatment of Thumb Carpometacarpal Joint Arthritis
NCT05005000 · Status: WITHDRAWN · Phase: PHASE2 · Type: INTERVENTIONAL
Last updated 2024-01-12
Summary
32 patients with Eaton-Glickel stage 2-3 CMC arthritis will be randomized to receive intraarticular MFAT or intraarticular corticosteroid injection. Patients with inflammatory arthritis or prior thumb base trauma or surgery will be excluded. Autologous adipose tissue will be harvested from the outer thigh or lower abdomen using local anesthesia. Tissue will be processed to remove oil and debris in-office using an FDA-approved commercially available device. The processed adipose will be immediately injected into the thumb CMC joint under fluoroscopic guidance. Visual analogue score (VAS), grip/pinch strength, Kapandji range of motion score, thumb disability examination, and QuickDASH score will be assessed pre-procedure and at 2 weeks, 6 weeks, 3 months, 6 months, and 12 months.
Conditions
Interventions
- BIOLOGICAL
-
Micro-Fragmented Adipose Tissue (MFAT)
1ml of autologous micro-fragmented adipose tissue will be used.
- DRUG
-
Triamcinolone Acetonide 10mg/mL
The control group will receive a 1ml intraarticular injection of triamcinolone acetonide 10mg/ml.
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
Jacques Hacquebord, MD · NYU Langone Health
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-05-12
- Primary Completion
- 2023-05-25
- Completion
- 2023-05-25
- FDA Drug
- Yes
Countries
- United States
Study Locations
More Related Trials
-
Autologous Adipose-Derived Stromal Cells Delivered Intra-articularly in Patients With Osteoarthritis.
NCT01739504 ·Status: TERMINATED ·Phase: NA
-
A Longitudinal, Multi-Center Safety Study of Autologous Adult Adipose-Derived Regenerative Cell Injection Into Chronic Partial-Thickness Rotator Cuff Tears
NCT05400798 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Safety and Feasibility Study of Mesenchymal Trophic Factor (MTF) for Treatment of Osteoarthritis
NCT02003131 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Arthroscopic Debridement Followed by Intra-articular Injection of Micro-fragmented Adipose Tissue in Patients Affected by Knee Osteoarthritis
NCT06545266 ·Status: COMPLETED
-
Treatment of Osteoarthritis With the Stromal Vascular Fraction of Abdominal Adipose Tissue - a Pilot Study
NCT02697682 ·Status: COMPLETED ·Phase: NA
-
Micro-fragmented Adipose Tissue Injection Associated With Arthroscopic Procedures in Patients With Knee Osteoarthritis
NCT03527693 ·Status: COMPLETED
-
Autologous Stromal Vascular Fraction in the Treatment of Thumb Basal Joint Osteoarthritis
NCT04455763 ·Status: UNKNOWN ·Phase: NA
-
Biological Characterization Study of an Autograft Nanofat (Nanocarabio)
NCT05915962 ·Status: COMPLETED ·Phase: NA
-
Intra-articular Transplantation of Autologous Adipose Derived Stromal Vascular Faction (SVF) for Treatment of Osteoarthritis of the Knee
NCT03940950 ·Status: COMPLETED ·Phase: PHASE1
-
Treatment of Osteoarthritis of the Hip Joint With Intra-articular Injection of Microfractured Autologous Adipose Tissue Containing Mesenchymal Stromal Cells.
NCT05465096 ·Status: COMPLETED ·Phase: NA
-
Outcomes Data of Adipose Stem Cells to Treat Osteoarthritis
NCT02241408 ·Status: UNKNOWN
-
Allograft Meniscal Arthroplasty for the Treatment of Basal Joint Arthritis of the Thumb
NCT01542515 ·Status: COMPLETED
-
Adipose-Derived Biocellular Regenerative Therapy for Osteoarthritis
NCT04238143 ·Status: RECRUITING ·Phase: NA
-
Safety and Feasibility Study of Autologous Stromal Vascular Fraction (SVF) Cells for Treatment of Osteoarthritis
NCT01885832 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Lipogems Prospective Study
NCT03922490 ·Status: TERMINATED ·Phase: PHASE4
-
A Disease-based Treatment Study for Diagnosed Osteoarthritis Utilizing Adipose-derived Regenerative Cells
NCT04405297 ·Status: TERMINATED
-
Safety of Adipose-derived Regenerative Cells Injection for Treatment of Osteoarthritis of the Facet Joint
NCT03513731 ·Status: RECRUITING ·Phase: NA
-
Study of TG-C in Patients With Grade 3 Degenerative Joint Disease of the Knee
NCT01221441 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of α MAT Versus Steroid Injection in Knee Osteoarthritis (STα MAT-knee Study)
NCT04230902 ·Status: UNKNOWN ·Phase: PHASE3
-
Use of FlexHD as Post Trapeziectomy Spacer
NCT01998594 ·Status: COMPLETED ·Phase: PHASE4
-
A Phase 1/2a to Evaluate the Safety and Efficacy of Adipose Tissue Allograft (BRC-OA) in Patients With Osteoarthritis of the Knee
NCT06828666 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
Synovial Tissue and Fat Pad Stromal Vascular Fraction Bioengineering in Patients With Knee Articular Cartilage Injury
NCT05120700 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Microfragmented Adipose Tissue Versus Platelet-rich Plasma for Knee Osteoarthritis: a Randomized Comparative Trial
NCT04351087 ·Status: COMPLETED ·Phase: NA
-
Arthroscopic Autologous Chondrocyte Implantation Versus Microfractures
NCT01947374 ·Status: COMPLETED ·Phase: PHASE3
-
Microdrilling Surgery for Full Thickness Chondral Lesions of the Knee Augmented With Concentrated Bone Marrow Aspirate, Platelet Rich Plasma and Hyaluronic Acid
NCT02285725 ·Status: COMPLETED ·Phase: NA